STING CDN agonist IFM Therapeutics |CAS:2197188-04-6 Probechem Biochemicals

You are here:Home-Chemical Inhibitors & Agonists-Immunology/Inflammation-STING-STING CDN agonist IFM Therapeutics

Chemical Structure : STING CDN agonist IFM Therapeutics

Catalog No.: PC-35547Not For Human Use, Lab Use Only.

STING CDN agonist IFM Therapeutics is a synthetic cyclic dinucleotide (CDN) agonist of STING, stimulates potent immunity against cancer..

Packing	Price	Stock	Quantity
1 mg		Get quote
5 mg		Get quote
25 mg		Get quote

Get Quotation Now

or Bulk Inquiry

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

STING CDN agonist IFM Therapeutics is a synthetic cyclic dinucleotide (CDN) agonist of STING, stimulates potent immunity against cancer.

M.Wt	582.542
Formula	C22H26N14O6
Appearance	Solid
CAS No.
Storage	Solide Powder -20 °C 12 Months; 4°C 6 Months	In Solvent -80 °C 6 Months; -20°C 6 Months
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	(2R,3R,3aS,7aR,9R,10R,10aS,14aR)-2,9-bis(6-amino-9H-purin-9-yl)-3,10-dihydroxydodecahydrodifuro[3,2-d:3',2'-j][1,3,7,9]tetraazacyclododecine-5,12(4H,6H)-dione

1. Patent WO 2018045204.